Gene therapy for HIV infection: what does it need to make it work?

Gene therapy for HIV infection: what does it need to make it work?
复制标题

HIV 感染的基因疗法:需要什么才能发挥作用?

DOI:
--
复制
发表时间:
2006
影响因子:
3.5
通讯作者:
K. Hasselmann
K. Hasselmann
中科院分区:
医学4区
文献类型:
--
作者:
D. von Laer;S. Hasselmann;K. Hasselmann

文献摘要

参考文献

被引文献

相似文献

抗病毒药物治疗HIV感染的疗效受到毒性和病毒耐药性的限制。因此,需要探索替代疗法。已经开发了几种用于HIV感染的基因治疗策略,但是在临床测试中没有达到治疗有效水平的转基因产物。本文综述了影响治疗效果的决定因素,并讨论了目前HIV感染基因治疗方法的潜力和局限性。版权所有© 2006约翰威利父子有限公司。
The efficacy of antiviral drug therapy for HIV infection is limited by toxicity and viral resistance. Thus, alternative therapies need to be explored. Several gene therapeutic strategies for HIV infection have been developed, but in clinical testing therapeutically effective levels of the transgene product were not achieved. This review focuses on the determinants of therapeutic efficacy and discusses the potential and also the limits of current gene therapy approaches for HIV infection. Copyright © 2006 John Wiley & Sons, Ltd.
通过直接股骨内注射进行体内逆转录病毒基因转移可纠正 Jak3 敲除动物的 SCID 表型。
DOI: 10.1182/blood-2002-12-3859
发表时间: 2003
期刊: Blood
影响因子: 20.3
作者:
McCauslin,ChristineS;Wine,John;Cheng,Linzhao;Klarmann,KimD;Candotti,Fabio;Clausen,PeterA;Spence,SallyE;Keller,JonathanR
通讯作者: Keller,JonathanR
DOI: 10.1006/mthe.2002.0611
发表时间: 2002-06-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Deeks, SG;Wagner, B;Hege, KM
通讯作者: Hege, KM
DOI: 10.1016/s0301-472x(00)00158-2
发表时间: 2000
影响因子: 2.6
作者:
Porada,CD;Tran,ND;Zhao,Y;Anderson,WF;Zanjani,ED
通讯作者: Zanjani,ED
DOI: 10.1089/hum.2005.16.1065
发表时间: 2005-09-01
期刊: HUMAN GENE THERAPY
影响因子: 4.2
作者:
Morgan, RA;Walker, R;Lane, HC
通讯作者: Lane, HC
DOI: 10.1073/pnas.95.3.1201
发表时间: 1998-02-03
影响因子: 11.1
作者:
Ranga, U;Woffendin, C;Nabel, GJ
通讯作者: Nabel, GJ